knowledge -WSS

knowledge

author：explore 2025-09-27 09:44:38 - browse：56826

Stock photo of a surgeon holding a digital tablet in a medical setting – health tech coverage from STAT — Adobe

A new $50 million nonprofit initiative aims to independently evaluate health technologies’ impact on costs and quality, an attempt to help patients, payers, and providers sort over-hyped products from ones that actually move the needle.

The Peterson Center on Healthcare, a nonprofit supporting programs that raise care quality and drive down costs, announced the new Peterson Health Technology Institute Tuesday. The institute plans to publish its methodology for assessing new health technology as soon as September, and start publishing reports on specific sectors, like disease types or tech mechanisms, in 2024, executive director Caroline Pearson told STAT.

Especially after digital health investment surged early in the pandemic, health apps and software have proliferated — both those marketed to consumers and designed for organizations like health systems or insurers. Venture funding has since contracted, but customers are still faced with “an overwhelming number of solutions,” Pearson said. “It’s hard to know what is high value in this space.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： How one medical school became remarkably diverse
Next article： Neurocrine congenital adrenal hyperplasia trial succeeds

entertainment

WSS

Medicare Advantage proposed rates disappoint insurers

Transgender sports debate: Physicians say bans are health issue

Medicare threatens to cut off funding for HCA's Mission hospital

Readout Newsletter: Biogen, Rocket Pharma, KalVista, and more

Why the drug industry's warnings on the IRA's impact fall short

House panel takes first step toward fixing drug shortages

focus

knowledge

entertainment

After affirmative action ruling, medical educators look to 'holistic review'

Robert F. Kennedy is pitching centrism on health, even on abortion

Heart attack and stroke risk calculators need revising

What happened to the House vote on health price transparency?

Medical leaders decry Supreme Court decision on affirmative action

KalVista pill reduced swelling 'attacks' caused by genetic disease

At least 13 dead in Texas as scorching temps continue

House panel takes first step toward fixing drug shortages

BioMarin wins approval for gene therapy to treat hemophilia A

FDA weighs limits of animal data in assessing artificial wombs

Wikipedia

Industry veterans launch new biotech VC with $310M

Grad students accuse University of California of wage theft

Covid’s new normal has set in amid another rise in cases

'A game

What we’ve learned from the Aduhelm mess

Gilead might be held responsible for not developing a drug

entertainment

hotspot

explore

focus